EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First‐Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older

Hisashi Noma iD, Hiroshi Sunada, Taiki Sugimoto iD, Ken-Ei Sada iD, Futoshi Oda, Megumi Maeda, Haruhisa Fukuda

Journal of the American Geriatrics Society · 2026-07 · 74 (7) · 1938-1949

DOI: 10.1111/jgs.70463 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 26.04.2026. Verfasst von Hisashi Noma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Statistical Mathematics, The Institute of Statistical Mathematics, Tokyo, Japan. Hauptthemen laut MEDLINE: Calcium Channel Blockers, Antihypertensive Agents, Angiotensin Receptor Antagonists, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence guiding first‐line antihypertensive drug choice in adults aged 75 years or older is limited, despite widespread use of angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) in late older age.

Methods

We conducted a target trial emulation using a new‐user design in a nationwide linked healthcare claims database in Japan. Adults aged ≥ 75 years who had no prescription of either drug class in the preceding 12 months and initiated an ARB ( n = 10,037) or a CCB ( n = 19,785) were followed from treatment initiation. The primary outcome was all‐cause mortality; secondary outcomes included hospitalization for heart failure, myocardial infarction, stroke, and major adverse cardiovascular events (MACE). Intention‐to‐treat effects were estimated using inverse probability of treatment and censoring weighting with pooled logistic regression models.

Results

Among 29,822 patients, median follow‐up was 4.0 years. During follow‐up, 3487 deaths occurred. ARB therapy was associated with lower all‐cause mortality than CCB therapy (hazard ratio [HR], 0.885; 95% CI, 0.823–0.951). The estimated 5‐year risk of death was 12.7% for ARB users and 14.8% for CCB users (absolute risk difference, −2.1 percentage points; 95% CI, −3.1 to −1.0). ARB therapy was also associated with lower risks of heart failure hospitalization (HR, 0.843; 95% CI, 0.774–0.918), myocardial infarction (HR, 0.867; 95% CI, 0.795–0.945), stroke (HR, 0.931; 95% CI, 0.869–0.998), and MACE (HR, 0.889; 95% CI, 0.848–0.931). Associations were consistent across age subgroups, including adults aged ≥ 85 years.

Conclusion

In adults aged 75 years or older, ARB‐based antihypertensive therapy was associated with lower risks of mortality and cardiovascular events compared with CCB‐based therapy. These findings suggest that first‐line antihypertensive drug choice may have prognostic implications in late older age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channel BlockersAntihypertensive AgentsAngiotensin Receptor AntagonistsHypertensionHumansAgedMaleFemaleJapanAged, 80 and overHeart FailureStroke

Stichwörter der Autor:innen

antihypertensive therapyheart failuremortalityolder adultstarget trial emulation

Substanzen

Calcium Channel BlockersAntihypertensive AgentsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Department of Interdisciplinary Statistical Mathematics, The Institute of Statistical Mathematics, Tokyo, Japan.
  • The Graduate Institute for Advanced Studies, the Graduate University for Advanced Studies (SOKENDAI), Tokyo, Japan.
  • Advanced Medicine, Innovation and Clinical Research Center, Tottori University Hospital, Tottori, Japan.
  • Department of Prevention and Care Science, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Department of Clinical Epidemiology, Kochi Medical School, Kochi, Japan.
  • Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

ORCID-Profile: Hisashi Noma, Taiki Sugimoto, Ken-Ei Sada

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Noma, H., Sunada, H., Sugimoto, T., Sada, K. E., Oda, F., Maeda, M., & Fukuda, H. (2026). Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First‐Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older. Journal of the American Geriatrics Society, 74(7), 1938-1949. https://doi.org/10.1111/jgs.70463

Vancouver

Noma H, Sunada H, Sugimoto T, Sada KE, Oda F, Maeda M, et al. Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First‐Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older. Journal of the American Geriatrics Society. 2026;74(7):1938-1949. doi:10.1111/jgs.70463

BibTeX
@article{Noma2026,
  author = {Noma, Hisashi and Sunada, Hiroshi and Sugimoto, Taiki and Sada, Ken-Ei and Oda, Futoshi and Maeda, Megumi and Fukuda, Haruhisa},
  title = {Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First‐Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  volume = {74},
  number = {7},
  pages = {1938--1949},
  doi = {10.1111/jgs.70463}
}
Kostenlos starten →